{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:37:58Z","timestamp":1777905478515,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["CIFMS 2021-I2M-1-003"],"award-info":[{"award-number":["CIFMS 2021-I2M-1-003"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Mucopolysaccharidosis Type II (MPS II) is a rare, progressive and ultimately fatal X-linked lysosomal storage disorder caused by mutations in the iduronate-2-sulfatase (IDS) gene. This report conducted a retrospective analysis to investigate the clinical characteristics, genotypes and management strategies in a large cohort of Chinese patients with MPS II.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this study, we explored 130 Chinese patients with MPS II between September 2008 and April 2022. Clinical manifestations, auxiliary examination, IDS pathogenic gene variants and IDS enzyme activity, surgical history were analysed in the study.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 130 patients were enrolled and the mean age at diagnosis was 5\u00a0years old. This study found the most common symptoms in our patients were claw-like hands, followed by coarse facial features, birthmarks (Mongolian spot), delayed development, inguinal or umbilical hernia. The most commonly cardiac manifestations were valve abnormalities, which were mitral\/tricuspid valve regurgitation (71.9%) and aortic\/pulmonary valve regurgitation (36.8%). We had found 43 different IDS pathogenic gene variants in 55 patients, included 16 novel variants. The variants were concentrated in exon 9 (20% = 11\/55), exon 3 (20% = 11\/55) and exon 8 (15% = 8\/55). A total of 50 patients (38.5%) underwent surgical treatment, receiving a total of 63 surgeries. The average age of first surgery was 2.6\u00a0years, and the majority of surgery (85.7%, 54\/63) was operated before 4\u00a0years old. The most common and earliest surgery was hernia repair. Three patients were died of respiratory failure.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study provided additional information on the clinical, cardiac ultrasound and surgical procedure in MPS II patients. Our study expanded the genotype spectrum of MPS II. Based on these data, characterization of MPS II patients group could be used to early diagnosis and treatment of the disease.<\/jats:p>","DOI":"10.3389\/fgene.2023.1103620","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T04:55:50Z","timestamp":1673585750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type II: A single-center retrospective study in China"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhenjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingsheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"104447","DOI":"10.1016\/j.ejmg.2022.104447","article-title":"Genotype-phenotype spectrum of 130 unrelated Indian families with Mucopolysaccharidosis type II","volume":"65","author":"Agrawal","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ymgme.2013.08.011","article-title":"Mucopolysaccharidosis type II: Identification of 30 novel mutations among Latin American patients","volume":"111","author":"Brusius-Facchin","year":"2014","journal-title":"Mol. Genet. Metabolism"},{"key":"B3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/jhg.2015.155","article-title":"Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China","volume":"61","author":"Chen","year":"2016","journal-title":"J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12881-020-01051-9","article-title":"The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients","volume":"21","author":"Chkioua","year":"2020","journal-title":"BMC Med. Genet."},{"key":"B5","first-page":"316","article-title":"Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome","volume":"51","author":"Clarke","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/hmg\/ddx069","article-title":"Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II","volume":"26","author":"Costa","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"15786","DOI":"10.1038\/ncomms15786","article-title":"Insights into Hunter syndrome from the structure of iduronate-2-sulfatase","volume":"8","author":"Demydchuk","year":"2017","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cca.2021.11.019","article-title":"Molecular analysis and novel variation identification of Chinese pedigrees with mucopolysaccharidosis using targeted next-generation sequencing","volume":"524","author":"Fang","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"B9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5582\/irdr.2019.01090","article-title":"Marketing of drugs for rare diseases is speeding up in China: Looking at the example of drugs for mucopolysaccharidosis","volume":"8","author":"Kang","year":"2019","journal-title":"Intractable Rare Dis. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2016.05.003","article-title":"Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase","volume":"118","author":"Kosuga","year":"2016","journal-title":"Mol. Genet. Metabolism"},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-021-01743-2","article-title":"Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II","volume":"16","author":"Lin","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13023-018-0827-1","article-title":"Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: Data from the hunter Outcome Survey (HOS)","volume":"13","author":"Lin","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-016-0471-6","article-title":"Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995\u20132012","volume":"11","author":"Lin","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/GIM.0b013e3181f6e74d","article-title":"Importance of surgical history in diagnosing mucopolysaccharidosis type II (hunter syndrome): Data from the hunter Outcome Survey","volume":"12","author":"Mendelsohn","year":"2010","journal-title":"Genet. Med."},{"key":"B17","first-page":"455","article-title":"The hunter syndrome in females: Is there an autosomal recessive form of iduronate sulfatase deficiency?","volume":"29","author":"Neufeld","year":"1977","journal-title":"Am. J. Hum. Genet."},{"key":"B18","first-page":"1202","article-title":"Mucopolysaccharidosis type II (hunter syndrome): Mutation \"hot spots\" in the iduronate-2-sulfatase gene","volume":"59","author":"Rathmann","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/21678707.2017.1296761","article-title":"Presentation and treatments for mucopolysaccharidosis type II (MPS II; hunter syndrome)","volume":"5","author":"Stapleton","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cga.12264","article-title":"Novel sequence variants in the MKKS gene cause Bardet-Biedl syndrome with intra- and inter-familial variable phenotypes","volume":"58","author":"Ullah","year":"2018","journal-title":"Congenit. Anom. (Kyoto)"},{"key":"B22","first-page":"482","article-title":"Sequence variants in four genes underlying Bardet-Biedl syndrome in consanguineous families","volume":"23","author":"Ullah","year":"2017","journal-title":"Mol. Vis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/a:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/gim.0b013e31817701e6","article-title":"Initial report from the hunter Outcome Survey","volume":"10","author":"Wraith","year":"","journal-title":"Genet. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"","journal-title":"Eur. J. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e22951","DOI":"10.1371\/journal.pone.0022951","article-title":"Analysis of the IDS gene in 38 patients with hunter syndrome: The c.879G>A (p.Gln293Gln) synonymous variation in a female create exonic splicing","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2019.01.009","article-title":"Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants","volume":"491","author":"Zhang","year":"2019","journal-title":"Clin. Chim. Acta"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1103620\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T04:55:54Z","timestamp":1673585754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1103620\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":27,"alternative-id":["10.3389\/fgene.2023.1103620"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1103620","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"article-number":"1103620"}}